Oral contraceptives coronary heart disease industrialized countries coronary heart disease CHD major public health problem men women Preventive strategies excessive mortality morbidity CHD identification modification metabolic factors disease process major areas concern lipid metabolism carbohydrate metabolism hemostatic system steroid hormones oral contraceptives OCs areas many instances metabolic markers CHD directions risk evidence changes CHD users modern low-dose OCs prudent formulations minimal impact metabolic risk markers evidence many metabolic disturbances CHD patients share common origin development risk-free OCs likely investigation complex interrelationships 